Circulating biomarkers of tissue remodelling in pulmonary hypertension
Authors:
- 7 May 2010
- journal article
- research article
- Published by Taylor & Francis in Biomarkers
- Vol. 15 (6) , 523-532
Abstract
Objective: Besides persisting high pulmonary arterial pressure and increased pulmonary vascular resistance, remodelling of pulmonary tissues and subsequently the right heart are the key pathomechanisms of pulmonary hypertension (PH). Extracellular matrix maintenance in this context plays a central role. Methods: We tested the hypothesis that plasma concentration of matrix metalloproteinase (MMP)-2, tissue inhibitor of matrix metalloproteinases (TIMP)-4 and tenascin C (TNC) might be useful as biomarkers for assessing the severity of PH. Therefore, the concentrations of MMP-2, TIMP-4, TNC and N-terminal b-type natriuretic peptide (NT-proBNP) of 36 PH patients were compared with those of 44 age- and gender-matched healthy volunteers. Additionally, lung function, 6-min walk distance and right heart function were assessed. Results: In PH patients, significantly elevated plasma levels of MMP-2, TIMP-4, TNC and NT-proBNP were detected. In particular, TIMP-4 was significantly increased in patients with higher NYHA classification, and in patients with severe right ventricular hypertrophy. Conclusion: Monitoring of plasma TIMP-4 and to a lesser extent of MMP-2 and TNC levels in PH patients might help to assess the beneficial effects of PH pharmacotherapy on tissue remodelling.Keywords
This publication has 37 references indexed in Scilit:
- Circulating Angiogenic Precursors in Idiopathic Pulmonary Arterial HypertensionThe American Journal of Pathology, 2008
- Endothelin receptor antagonists in pulmonary arterial hypertensionEuropean Respiratory Journal, 2008
- ACCF/ASE/ACEP/ASNC/SCAI/SCCT/SCMR 2007 Appropriateness Criteria for Transthoracic and Transesophageal Echocardiography⁎⁎Developed in accordance with the principles and methodology outlined by ACCF: Patel MR, Spertus JA, Brindis RG, Hendel RC, Douglas PS, Peterson E, Wolk MJ, Allen JM, Raskin IE. ACCF proposed method for evaluating the appropriateness of cardiovascular imaging. J Am Coll Cardiol 2005;46:1606-13 (1).JACC, 2007
- Emerging therapies for pulmonary arterial hypertensionExpert Opinion on Investigational Drugs, 2007
- Management of Pulmonary Arterial Hypertension With a Focus on Combination TherapiesThe Journal of Heart and Lung Transplantation, 2007
- Diagnostic and prognostic usefulness of natriuretic peptides in emergency department patients with dyspneaAnnals of Emergency Medicine, 2003
- ATS Statement: Guidelines for the Six-Minute Walk TestAmerican Journal of Respiratory and Critical Care Medicine, 2002
- Elastase and matrix metalloproteinase inhibitors induce regression, and tenascin-C antisense prevents progression, of vascular diseaseJournal of Clinical Investigation, 2000
- An Imbalance between the Excretion of Thromboxane and Prostacyclin Metabolites in Pulmonary HypertensionNew England Journal of Medicine, 1992
- Survival in Patients with Primary Pulmonary HypertensionAnnals of Internal Medicine, 1991